Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 600-026-8 | CAS number: 1000817-22-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicological Summary
- Administrative data
- Workers - Hazard via inhalation route
- Workers - Hazard via dermal route
- Workers - Hazard for the eyes
- Additional information - workers
- General Population - Hazard via inhalation route
- General Population - Hazard via dermal route
- General Population - Hazard via oral route
- General Population - Hazard for the eyes
- Additional information - General Population
Administrative data
Workers - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 23.5 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 75
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 1 763.15 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Workers - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
Workers - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - workers
Worker:
Based on the available data, Fatty acids, C8-18 and C18-unsatd., reaction products with diethanolamine and propylene oxide (Kerocom FM 38), has to be considered as posing the risk of serious damage to the eye (R41; Cat. 1), as potentially skin sensitizing (R43; Cat. 1B), and also has a weak skin irritation potential (R38, no classification according to CLP), respectively.
The primary routes of anticipated industrial and professional exposure of Kerocom FM 38, are via inhalation and skin contact. In industrial settings, ingestion is not an anticipated route of exposure, but has to be considered for the general population (see below).
Dermal short-term and long-term exposure – local and systemic effects:
The substance causes skin sensitization in experimental animals.
For these effects, a qualitative assessment was conducted:
Though sensitization reactions of the skin are generally regarded as threshold effect, deriving a threshold and setting a DNEL is very difficult in practice. As there are only worker uses reported where exposure can be minimized by the appropriate risk management measures and operational conditions, a qualitative assessment was regarded as the most appropriate. Therefore the use of gloves and the use of stringent risk management measures as outlined in ECHA guidance document Part E: Risk Characterization (Table E. 3-1, page 28-32) is required in order to prevent any skin contact with the test substance and thus the occurrence of skin sensitization.
The use of gloves and of stringent risk management measures will also protect the worker from any systemic dermal effects, short-term and long-term.
Professional workers can come in contact with the substance via fuel and lubricants. As the substance is only a weak to moderate skin sensitizer and present in fuel at concentrations well below the threshold for classification & labeling of 1 % for Cat. 1B skin sensitizers, the hazard for professional workers is negligible also taking into account that the use of gloves will prevent any occurrence of skin contact.
Inhalation long-term exposure – systemic effects:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats.
This point of departure was modified to get the corrected starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the "Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the 8-hour standard inhalation volume of rats versus humans, and for differences between the 8-hour inhalation volume of workers in rest versus workers in light activity, by multiplying with the corresponding factors (x 1/0.38 m³/kg/d x 6.7 m³/10 m³). The resulting corrected starting point for inhalation DNEL derivation for workers is equal to 1763.15 mg/m³.
For DNEL derivation, the following assessment factors (AF) were applied to the corrected starting point:
- Interspecies factor: 1
Besides the applied allometric scaling factors no additional interspecies factor has been used based on the fact that concerning inhalation, rodents like the rat are in general more sensitive compared to human as the rat's ventilation frequency is higher. Also anatomical differences as well as air flow patterns between rodents and humans have to be taken into account (Escher and Mangelsdorf, 2009; Batke et al, 2011; Bitsch et al, 2006).
- Intraspecies factor: 5 (ECHA Guidance)
- Exposure duration: 6 (ECHA Guidance)
- Remaining differences: 2.5 (ECHA Guidance)
- Dose-response: 1
Total AF = 1 x 5 x 6 x 2.5 x 1 = 75
Based on this calculation the resulting DNEL is 23.5 mg/m³.
- Batke M, Escher S, Hoffmann-Doerr S, Melber C, Messinger H, Mangelsdorf I.(2011).Evaluation of time extrapolation factors based on the database RepDose. Toxicology Letters 205 (2011) 122– 129.
- Escher S and Mangelsdorf I. (2009). Evaluation of risk assessment factors for inter-species and time-extrapolation. Toxicol Lett 189:S247-S248. 46th Congress of the European Societies of Toxicology, 13-16 September 2009, Dresden.
- Bitsch A, Jacobi S, Melber C, Wahnschaffe U, Simetska N, Mangelsdorf I. (2006).REPDOSE: A database on repeated dose toxicity studies of commercial chemicals – a multifunctional tool. Regul Toxicol Pharmacol 46:202-210.
-ECETOC (2003). Contact Sensitization: classification according to potency. Technical Report No. 87, April 2003.
-ECHA: REACh Guidance document R.8
-ECETOC (2003). Derivation of Assessment factors for Human Health Risk Assessment. Technical Report No. 86, February 2003.
-ECETOC (2010). Guidance on Assessment Factors to Derive DNELs.Technical Report No. 110, October 2010.
General Population - Hazard via inhalation route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 5.79 mg/m³
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 150
- Modified dose descriptor starting point:
- NOAEC
- Value:
- 869.56 mg/m³
- Explanation for the modification of the dose descriptor starting point:
- See Discussion
- Justification:
- See Discussion
- Justification:
- See Discussion
- Justification:
- See Discussion
- Justification:
- See Discussion
- Justification:
- See Discussion
- Justification:
- See Discussion
- Justification:
- See Discussion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- no hazard identified
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard via dermal route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.66 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- see discussion
- Justification:
- see discussion
- Justification:
- see discussion
- Justification:
- see discussion
- Justification:
- see discussion
- Justification:
- see discussion
- Justification:
- see discussion
- Justification:
- see discussion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
Local effects
Long term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Acute/short term exposure
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
- Most sensitive endpoint:
- sensitisation (skin)
General Population - Hazard via oral route
Systemic effects
Long term exposure
- Hazard assessment conclusion:
- DNEL (Derived No Effect Level)
- Value:
- 1.66 mg/kg bw/day
- Most sensitive endpoint:
- repeated dose toxicity
- Route of original study:
- Oral
DNEL related information
- DNEL derivation method:
- ECHA REACH Guidance
- Overall assessment factor (AF):
- 600
- Modified dose descriptor starting point:
- NOAEL
- Value:
- 1 000 mg/kg bw/day
- Explanation for the modification of the dose descriptor starting point:
- see discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
- Justification:
- See discussion
Acute/short term exposure
- Hazard assessment conclusion:
- no hazard identified
DNEL related information
General Population - Hazard for the eyes
Local effects
- Hazard assessment conclusion:
- medium hazard (no threshold derived)
Additional information - General Population
Consumer
Based on the available data, Fatty acids, C8-18 and C18-unsatd., reaction products with diethanolamine and propylene oxide (Kerocom FM 38), has to be considered as posing the risk of serious damage to the eye (R41; Cat. 1), as potentially skin sensitizing (R43; Cat. 1B), and also has a weak skin irritation potential (R38, no classification according to CLP), respectively.
For the general population, all three possible routes of exposure (oral, dermal, inhalation) have to be taken into account.
Dermal short-term and long-term exposure – local effects:
Consumers can come in contact with the substance via fuel and lubricants. As the substance is only a weak to moderate skin sensitizer and present in consumer products well below the threshold for classification & labeling of 1 % for Cat. 1B skin sensitizers, the hazard for consumers is negligible.
Dermal long-term exposure – systemic effects:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term dermal exposure. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats.
The NOAEL of 1000 mg/kg bw/day was considered appropriate as point of departure for DNEL derivation. As some dermal uptake is evident (the substance is a skin sensitizer), no correction for differences between oral and dermal uptake was made although dermal uptake is assumed to be lower than oral uptake (see toxicokinetic assessment). Subsequently, the following assessment factors are taken into account for the final DNEL calculation for the oral route: interspecies differences (4), remaining differences (2.5), intraspecies differences (10), exposure duration (6) (AF = 4 x 2.5 x 10 x 6 x 1 x 1 = 600).
As a consequence, the resulting DNEL for long-term dermal systemic effects is 1.66 mg/kg bw/d for the general population.
For DNEL derivation, the following assessment factors (AF) were applied to the corrected starting point:
- Interspecies factor: 4 (ECHA Guidance)
- Intraspecies factor: 10 (ECHA Guidance)
- Remaining differences: 2.5 (ECHA Guidance)
- Exposure duration: 6 (ECHA Guidance)
- Dose-response: 1
Inhalation long-term exposure – systemic effects:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term exposure following inhalation. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats.
This point of departure was modified to get the correct starting point for DNEL derivation. As a first step, route-to-route extrapolation was performed as recommended in the "Guidance on information requirements and chemical safety assessment, Chapter R.8, p. 26 f.:
The oral rat NOAEL was converted into the inhalative human NOAEC corrected for differences between the 24-hour standard inhalation volume of rats versus humans by multiplying with the corresponding factor (x 1/1.15 m³/kg/d). The resulting corrected starting point for inhalation DNEL derivation for the general population is equal to 869.56 mg/m³.
For DNEL derivation, the following assessment factors (AF) were applied to the corrected starting point:
- Interspecies factor: 1
Besides the applied allometric scaling factors no additional interspecies factor has been used based on the fact that concerning inhalation, rodents like the rat are in general more sensitive compared to human as the rat's ventilation frequency is higher. Also anatomical differences as well as air flow patterns between rodents and humans have to be taken into account (Escher and Mangelsdorf, 2009; Batke et al, 2011; Bitsch et al, 2006).
- Intraspecies factor: 10 (ECHA Guidance)
- Remaining differences: 2.5
- Exposure duration: 6 (Batke et.al., 2011)
- Dose-response: 1
Total AF = 1 x 10 x 2.5 x 6 x 1= 150
Based on this calculation the resulting DNEL is 5.79 mg/m³.
Oral long-term exposure – systemic effects:
The NOAEL from an oral repeated dose study with rats conducted according to OECD TG 407 (BASF, 2009) was identified as the appropriate starting point for DNEL derivation for long-term oral exposure. The NOAEL for general, systemic toxicity of the test substance was 1000 mg/kg bw/d for rats.
The NOAEL of 1000 mg/kg bw/day was considered appropriate as point of departure for DNEL derivation. Subsequently, the following assessment factors are taken into account for the final DNEL calculation for the oral route: interspecies differences (4), remaining differences (2.5), intraspecies differences (10), exposure duration (6) (AF = 4 x 10 x 2.5 x 6 x 1 x 1 = 600).
As a consequence, the resulting DNEL for long-term oral systemic effects is 1.66 mg/kg bw/d for the general population.
For DNEL derivation, the following assessment factors (AF) were applied to the corrected starting point:
- Interspecies factor: 4 (ECHA Guidance)
- Intraspecies factor: 10 (ECHA Guidance
- Remaining differences: 2.5 (ECHA Guidance)
- Exposure duration: 6 (ECHA Guidance)
- Dose-response: 1
- Batke M, Escher S, Hoffmann-Doerr S, Melber C, Messinger H, Mangelsdorf I.(2011).Evaluation of time extrapolation factors based on the database RepDose. Toxicology Letters 205 (2011) 122– 129.
- Escher S and Mangelsdorf I. (2009). Evaluation of risk assessment factors for inter-species and time-extrapolation. Toxicol Lett 189:S247 -S248. 46th Congress of the European Societies of Toxicology, 13-16 September 2009, Dresden.
- Bitsch A, Jacobi S, Melber C, Wahnschaffe U, Simetska N, Mangelsdorf I. (2006).REPDOSE: A database on repeated dose toxicity studies of commercial chemicals – a multifunctional tool. Regul Toxicol Pharmacol 46:202-210.
-ECETOC (2003). Contact Sensitization: classification according to potency. Technical Report No. 87, April 2003.
-ECHA (2008). REACh Guidance document R.8
-ECETOC (2003). Derivation of Assessment factors for Human Health Risk Assessment. Technical Report No. 86, February 2003.
-ECETOC (2010). Guidance on Assessment Factors to Derive DNELs.Technical Report No. 110, October 2010.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.